SCHOLAR ROCK HOLDING CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.03 USD | +2.22% |
|
-12.33% | -41.76% |
| 23/05 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
| 22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Scholar Rock Conf...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of medicines for the treatment of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. The Company's product candidate includes apitegromab, an inhibitor of the activation of latent myostatin for the treatment of spinal muscular atrophy (SMA) and is in the treatment of other myostatin-related disorders. Its product candidate also includes SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 (TGF?1) for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies. The Company is advancing multiple antibody profiles toward product candidate selection, including antibodies that selectively inhibit the activation of latent TGF?1 in the context of fibrotic extracellular matrix and that avoid perturbing TGF?1 presented by cells of the immune system.
Calendar
Related indices
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
10.79
USD
Average target price
26.25
USD
Spread / Average Target
+143.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.76% | 861M | |
| +11.93% | 116B | |
| +12.32% | 106B | |
| -8.43% | 23.89B | |
| -2.56% | 21.58B | |
| -10.77% | 18.96B | |
| -40.50% | 16.96B | |
| -13.61% | 16.33B | |
| +6.61% | 14.14B | |
| +32.71% | 12.02B |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Transcript : Scholar Rock Holding Corporation - Special Call
